Buscar | Webyourself Social Media Platform

Purvaja Jadhao agrega un archivo Other
2024-03-22 13:51:11 -

Advances in Chronic Obstructive Pulmonary Disease Treatment
COPD is a progressive lung disease that makes it hard to breathe. Over time, COPD gets worse and the lungs lose their ability to fully inflate and deflate properly. This damages the lungs and weakens the muscles that help with breathing. As COPD gets more severe, even minimal physical activity can become very tiring. There is no cure for COPD, but treatment can help manage symptoms, slow its...

0 Commentarios 0 Acciones 1206 Views 0 Vista previa

Please log in to like, share and comment!
Rohit Harne agrega un archivo Health
2024-11-19 13:43:13 -

Asia-Pacific chronic obstructive pulmonary disease copd market Expanding Access to Innovative Treatments Forecast 2032
North America The North American Chronic obstructive pulmonary disease copd market is a significant contributor globally, driven by the high prevalence of COPD, increasing awareness regarding respiratory diseases, and advanced healthcare infrastructure. The market benefits from the availability of innovative therapies and devices for COPD management. The United States dominates this...

0 Commentarios 0 Acciones 102 Views 0 Vista previa

Please log in to like, share and comment!
SHAM Bhau agrega un archivo Other
2024-06-13 17:40:26 -

Chronic Obstructive Pulmonary Disease Market Size, Industry Trends and Forecast to 2030
The global Chronic Obstructive Pulmonary Disease Market research report 2030, as published by Data bridge Market Research, provides insights into the current global outlook and key regions, examining Major Players, Countries, Product Types, and end industries. It focuses on top players in the global market and categorizes the market based on several parameters....

0 Commentarios 0 Acciones 640 Views 0 Vista previa

Please log in to like, share and comment!
Alex Joe agrega un archivo Other
2023-04-28 11:55:27 -

Chronic Obstructive Pulmonary Disease (COPD) devicesMarket Trends, Revenue, Major Players, Share Analysis & Forecast Till 2032
The Chronic Obstructive Pulmonary Disease (COPD) devices market is expected to see a steady increase in revenue from USD 8.3 billion in 2022 to USD 14.02 billion in 2032, with a Compound Annual Growth Rate (CAGR) of 6%. This growth is driven by several factors, including the increasing prevalence of COPD globally, a growing number of elderly people, and a rising demand for non-invasive devices....

0 Commentarios 0 Acciones 2160 Views 0 Vista previa

Please log in to like, share and comment!
Renub Research Research agrega un archivo Other
2024-09-04 08:43:08 -

Chronic Obstructive Pulmonary Disease (COPD) Market Size And Forecast 2024-2032
Chronic Obstructive Pulmonary Disease (COPD) Market Analysis The Global Chronic Obstructive Pulmonary Disease (COPD) Market was valued at US$ 13.25 billion in 2023. It is estimated that the market will be worth US$ 17.22 billion by 2032, with a projected compound annual growth rate (CAGR) of 2.96% from 2024 to 2032. Factors contributing to this growth include, increased use of cigarettes...

0 Commentarios 0 Acciones 325 Views 0 Vista previa

Please log in to like, share and comment!
Renub Research Research agrega un archivo Other
2024-09-04 08:43:10 -

Chronic Obstructive Pulmonary Disease (COPD) Market Size And Forecast 2024-2032
Chronic Obstructive Pulmonary Disease (COPD) Market Analysis The Global Chronic Obstructive Pulmonary Disease (COPD) Market was valued at US$ 13.25 billion in 2023. It is estimated that the market will be worth US$ 17.22 billion by 2032, with a projected compound annual growth rate (CAGR) of 2.96% from 2024 to 2032. Factors contributing to this growth include, increased use of cigarettes...

0 Commentarios 0 Acciones 351 Views 0 Vista previa

Please log in to like, share and comment!
Renub Research Research agrega un archivo Other
2024-09-14 09:24:19 -

Chronic Obstructive Pulmonary Disease (COPD) Market Size And Forecast Report 2024-2032
Chronic Obstructive Pulmonary Disease (COPD) Market Analysis The Global Chronic Obstructive Pulmonary Disease (COPD) Market was valued at US$ 13.25 billion in 2023. It is estimated that the market will be worth US$ 17.22 billion by 2032, with a projected compound annual growth rate (CAGR) of 2.96% from 2024 to 2032. Factors contributing to this growth include, increased use of cigarettes...

0 Commentarios 0 Acciones 278 Views 0 Vista previa

Please log in to like, share and comment!
Renub Research Research agrega un archivo Other
2024-09-14 09:24:20 -

Chronic Obstructive Pulmonary Disease (COPD) Market Size And Forecast Report 2024-2032
Chronic Obstructive Pulmonary Disease (COPD) Market Analysis The Global Chronic Obstructive Pulmonary Disease (COPD) Market was valued at US$ 13.25 billion in 2023. It is estimated that the market will be worth US$ 17.22 billion by 2032, with a projected compound annual growth rate (CAGR) of 2.96% from 2024 to 2032. Factors contributing to this growth include, increased use of cigarettes...

0 Commentarios 0 Acciones 286 Views 0 Vista previa

Please log in to like, share and comment!
Akash Pingale agrega un archivo Networking
2022-01-04 07:19:28 -

Chronic Obstructive Pulmonary Disease (COPD) Treatment market 2021 Comprehensive Research Methodology, Key Insights, Segments and Extensive Profiles by 2027
Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Overview: Chronic obstructive pulmonary disease (COPD) is a type of obstructive lung disease characterized by long-term breathing problems and poor airflow. Tobacco smoking is the most common cause of COPD, with factors such as air pollution and genetics. There are several lifestyle-related factors such as smoking, exposure to...

0 Commentarios 0 Acciones 3531 Views 0 Vista previa

Please log in to like, share and comment!
Purvaja Jadhao agrega un archivo Other
2024-03-15 09:59:05 -

Chronic Obstructive Pulmonary Disease (COPD) Treatment Market is driven by increasing prevalence of COPD
The chronic obstructive pulmonary disease (COPD) treatment market encompasses a broad range of therapeutics including bronchodilators, corticosteroids, and combination therapies used for alleviating symptoms and slowing progression of COPD. Some of the commonly prescribed medications include inhaled corticosteroids, short-acting beta-2 agonists, long-acting beta-2 agonists, anticholinergics,...

0 Commentarios 0 Acciones 1086 Views 0 Vista previa

Please log in to like, share and comment!

Resultados de la búsqueda